U.S. FDA approved first Respiratory Syncytial Virus (RSV) vaccine
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
On May 2, 2023, Elanco Animal Health announced that the U.S. Department of Agriculture had provided a conditional…
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On May 2, 2023, the U.S. FDA announced that it was taking additional steps to support the use…
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
On Apr. 27, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 27, 2020, the Zoonomia Project team announced in in a special issue of Science, that had…
On Apr. 27, 2023, On Apr. 27, 2023, researchers at Cornell University announced they had used ancient DNA…
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
On Apr. 25, 2023, the U.S. FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS)…
On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Ri�, Germany….
On Apr. 24, 2023, the U.S. FDA authorized Status COVID-19 Antigen Rapid Test for Home Use (manufactured by…
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
On Apr. 17, 2023, the U.S. FDA approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord…
On Apr. 15, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
On Apr. 14, 2023, the National Health Commission of the Peopleï¾’s Republic of China reported a confirmed case…
On Apr. 14, 2023, the U.S. FDA issued an emergency use authorization for the Azure Fastep COVID-19 Antigen…
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinsonï¾’s disease (PD), researchers announced…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Apr. 10, 2023, the U.S. Food and Drug Administration authorized for marketing Moximed’s MISHA Knee System, an…
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
On Apr. 5, 2023, researchers at Oregon Health & Science University’s OHSU Casey Eye Institute announced that gene…
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 5, 2023, the Food and Agriculture Organization (FAO), in collaboration with the World Health Organization (WHO),…
On Apr. 5, 2023, Aberdeen Proving Ground South, formerly known as Edgewood, celebrated the opening of the Department…